Translational Discovery and Validation Using Multi-omics Data from ER+ Breast Tumors
The focus of this webinar will be on two aspects of integrative analysis and translational research in the field of estrogen receptor-positive (ER+) breast cancer research. Namely, Dr. Meenakshi Anurag will discuss the identification of protein drivers of endocrine therapy resistance in ER+ breast cancer through pathway-centric analysis. She will also dive into hypothesis validation of her research through Clinical Proteomic Tumor Analysis Consortium (CPTAC)-generated patient profiling data and establishment of the roles of driver and biomarker proteins associated with treatment response.
This webinar is hosted by NCI’s Office of Cancer Clinical Proteomics Research (OCCPR). Registration is required. For questions, please contact La’Toya Kelly.
Dr. Meenakshi Anurag is an assistant professor at Baylor College of Medicine. Her primary research goal is to improve breast cancer diagnosis, treatment, and survival by precision data science.
Upcoming Events
- Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncologyJuly 30, 2024CCDI Federated Data: Enhancing Data DiscoverabilityAugust 13, 2024Leveraging High-Performance Computing Resources and Using QIIME 2 to Advance Your Microbiome ProjectsAugust 27, 2024 - August 29, 2024NCI Office of Data Sharing’s Annual Data Sharing Symposium: Driving Cancer Advances Through Impactful ResearchOctober 16, 2024The Cancer Research Data Commons 2024 Fall Symposium: Ten Years of Empowering Cancer ResearchersOctober 16, 2024 - October 17, 2024